Clinical Trials Directory

Trials / Completed

CompletedNCT00590317

Ondansetron vs Prochlorperazine for Nausea and Vomiting in the Emergency Department

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
64 (actual)
Sponsor
Emory University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study will compare the effect of prochlorperazine and ondansetron for the treatment of nausea and vomiting in the emergency department.

Detailed description

Nausea and vomiting can be common symptoms in the emergency department (ED). Antiemetics, agents to treat nausea and vomiting, include phenothiazine derivatives, prokinetic agents, and 5-HT3 antagonists. There have been limited studies on the use of these agents in the ED, and no direct comparisons to 5-HT3 antagonists have been published to date. Inclusion Criteria: Patients presenting to the ED with at least one of the following * nausea * vomiting documented in the ED

Conditions

Interventions

TypeNameDescription
DRUGProchlorperazinePatients receiving Prochlorperazine
DRUGOndansetronPatients receiving Ondansetron

Timeline

Start date
2005-03-01
Primary completion
2008-09-01
Completion
2008-09-01
First posted
2008-01-10
Last updated
2014-05-19
Results posted
2014-05-19

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00590317. Inclusion in this directory is not an endorsement.